Bio-Techne (TECH)
NASDAQ:TECH

Bio-Techne Stock Price & Analysis

309 Followers

TECH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$67.93 - $130.28
Previous Close$80.67
Volume154.15K
Average Volume (3M)1.26M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$203.07M
Total Debt (Recent Filing)$341.53M
Price to Earnings (P/E)45.2
Beta1.58
Next EarningsFeb 07, 2023
Dividend Yield1.28 (0.4%)
EPS (TTM)1.79
Shares Outstanding156,969,536
R-Squared0.49
Standard Deviation0.10
10 Day Avg. Volume841,925
30 Day Avg. Volume1,257,730
Price to Book (P/B)43.19
Price to Sales (P/S)11.33
Price to Cash Flow (P/CF)40.60
P/FCF Ratio85.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside194.09% Upside
Rating ConsensusStrong Buy
Alpha0.00963
Number of Analyst Covering9


Financials


Risk Analysis

Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

TECH FAQ

What was Bio-Techne’s price range in the past 12 months?
Bio-Techne lowest stock price was $67.93 and its highest was $130.28 in the past 12 months.
    What is Bio-Techne’s market cap?
    Currently, no data Available
    When is Bio-Techne’s upcoming earnings report date?
    Bio-Techne’s upcoming earnings report date is Feb 07, 2023 which is in 61 days.
      How were Bio-Techne’s earnings last quarter?
      Bio-Techne released its earnings results on Nov 01, 2022. The company reported $0.445 earnings per share for the quarter, missing the consensus estimate of $0.458 by -$0.013.
        Is Bio-Techne overvalued?
        According to Wall Street analysts Bio-Techne’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Bio-Techne pay dividends?
          Bio-Techne pays a Quarterly dividend of $0.08 which represents an annual dividend yield of 0.4%. Bio-Techne’s last Quarterly dividend payment was on Nov 28, 2022. Bio-Techne’s upcoming ex-dividend date is Nov 10, 2022
            What is Bio-Techne’s EPS estimate?
            Bio-Techne’s EPS estimate is $0.49.
              How many shares outstanding does Bio-Techne have?
              Bio-Techne has 156,969,540 shares outstanding.
                What happened to Bio-Techne’s price movement after its last earnings report?
                Bio-Techne reported an EPS of $0.445 in its last earnings report, missing expectations of $0.458. Following the earnings report the stock price went up 4.392%.
                  Which hedge fund is a major shareholder of Bio-Techne?
                  Among the largest hedge funds holding Bio-Techne’s share is Mairs & Power Inc. It holds Bio-Techne’s shares valued at 191M.

                    ---

                    Bio-Techne Stock Smart Score

                    The Bio-Techne stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Bio-Techne

                    Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Mettler-Toledo
                    Waters
                    PerkinElmer
                    West Pharmaceutical Services
                    Avantor

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis